It's an extremely common and effective medication used to prevent and break up blood clots and as part of a treatment protocol for atrial fibrillation (AFib). But does Eliquis have side effects? We ...

Apixaban (Eliquis) was associated with lower serious bleeding rates than rivaroxaban (Xarelto) or warfarin in patients with cirrhosis and atrial fibrillation (AF, Afib) in a nationwide cohort study.

For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban. Data remain inconclusive regarding ...

Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research presented in a Hot ...

Please provide your email address to receive an email when new articles are posted on . Asundexian did not prevent stroke or systemic embolism vs. apixaban in patients with atrial fibrillation despite ...

The study, known as the Apixaban versus Acetylsalicylic Acid to Prevent Strokes in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment (AVERROES) trial, ...

Please provide your email address to receive an email when new articles are posted on . Apixaban did not reduce recurrent stroke risk in patients with atrial cardiopathy without AF. The ARCADIA trial ...

Dear Dr. Roach: I am an 83-year-old man. Except for blood pressure medication, I've never had any heart-related health issues. Earlier this year, I experienced six or so episodes of a fast, irregular ...

DEAR DR. ROACH: I am an 83-year-old man. Except for blood pressure medication, I’ve never had any heart-related health issues. Earlier this year, I experienced six or so episodes of a fast, irregular ...

TRENTON, N.J. (AP) — Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that’s a potential blockbuster in a new ...